公司简介
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and rem...
关联新闻
- Medtronic Lifts Outlook, Invests Over $700 Million in Heart Tech & Robotics
Medtronic raised its outlook for the year after posting higher fiscal first-quarter profit and sales, driven by broad-based demand and contributions from newer growth platforms.
- Medtronic Stock Rises on Better-Than-Expected Earnings and $700 Million Investment in a Robot Surgeon
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment.
- Medtronic boosts fiscal 2027 forecasts on heart device demand
Medtronic raised the lower end of its fiscal 2027 profit forecast and revenue growth outlook on Tuesday, banking on strong demand for its heart devices used in complex cardiovascular procedures.
- I've Got Royalty on the Brain
And how could I not? After exploring Brighton Beach and Bristol, and then Cornwall all the way to St. Ives and Penzance, I wrapped up my Great Britain trip with a couple days in London.